Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SBO-154 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on SBO-154, a putative antibody-drug conjugate (ADC) targeting MUC1 (Jul 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SBO-154 | SBO154|SBO 154 | MUC1 Antibody 8 | Limited information is currently available on SBO-154, a putative antibody-drug conjugate (ADC) targeting MUC1 (Jul 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07042100 | Phase I | SBO-154 | A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. | Recruiting | USA | AUS | 1 |